Short Interest in Awakn Life Sciences Corp. (OTCMKTS:AWKNF) Decreases By 98.6%

Awakn Life Sciences Corp. (OTCMKTS:AWKNF) was the target of a significant decline in short interest in November. As of November 15th, there was short interest totalling 100 shares, a decline of 98.6% from the October 31st total of 7,100 shares. Based on an average trading volume of 44,400 shares, the short-interest ratio is currently 0.0 days.

Awakn Life Sciences Price Performance

OTCMKTS:AWKNF opened at $0.09 on Thursday. Awakn Life Sciences has a one year low of $0.05 and a one year high of $0.19. The company’s 50-day simple moving average is $0.08 and its 200 day simple moving average is $0.09.

Awakn Life Sciences Company Profile

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD.